Filgotinib maintained a favorable safety and efficacy profile for up to 8 years among patients with RA who participated in the DARWIN 3 LTE.

In a US study, researchers found that 35% of adults with IBD screened positive for spondyloarthritis, despite having no known SpA diagnosis.

Emapalumab-Izsg is under the FDA’s Priority Review for hemophagocytic lymphohistiocytosis/macrophage activation syndrome in Still disease.

A presidential advisory has been published by the AHA regarding US government funding for the National Institutes of Health.

Chronic diseases misdiagnosed as psychosomatic can lead to long-term damage to patients' physical and mental well-being.

GLP-1 receptor agonists are not associated with an increased risk for suicidality compared with DPP-4 inhibitors or SGLT-2 inhibitors.

Individuals with pemphigus vulgaris treated with low-dose methotrexate in addition to corticosteroids achieved faster reduction in glucocorticoid use compared with patients treated with ...